Lonza Group AG (OTCMKTS:LZAGY) Short Interest Update

Lonza Group AG (OTCMKTS:LZAGY) was the recipient of a significant growth in short interest in the month of June. As of June 15th, there was short interest totalling 52,400 shares, a growth of 4,663.6% from the May 31st total of 1,100 shares. Based on an average trading volume of 71,700 shares, the short-interest ratio is presently 0.7 days.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank upgraded shares of Lonza Group to a “strong-buy” rating in a research note on Sunday, June 23rd.

Lonza Group Trading Up 0.5 %

LZAGY traded up $0.27 during midday trading on Friday, reaching $54.50. The company had a trading volume of 15,130 shares, compared to its average volume of 114,512. Lonza Group has a 12-month low of $34.19 and a 12-month high of $64.88. The business has a 50-day moving average price of $55.74 and a two-hundred day moving average price of $51.89. The company has a quick ratio of 1.20, a current ratio of 1.77 and a debt-to-equity ratio of 0.27.

Lonza Group Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, May 29th. Shareholders of record on Thursday, May 16th were given a $0.0995 dividend. The ex-dividend date was Wednesday, May 15th.

Lonza Group Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.